Member Exclusive News

The week in industry: First and only medical prevention tool against dengue granted priority review

This week: AstraZeneca sheds products outside its core therapy areas and collaboration will develop targeted immunotherapy.

Go to the profile of RxNet
Nov 01, 2018

Please sign in or register for FREE

No comments yet.